KG
Kumudini Girishkumar Sanghani
About Kumudini Girishkumar Sanghani
Data last updated:
Kumudini Girishkumar Sanghani has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Viveda Wellness Retreat Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Viveda Wellness Retreat Private Limited at ₹5.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Oct 2020 | 2014 | ₹5.98 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumudini Girishkumar Sanghani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumudini Girishkumar Sanghani
Kumudini Girishkumar Sanghani has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Viveda Wellness Retreat Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Viveda Wellness Retreat Private Limited at ₹5.98 Cr (FY 2024).
Kumudini Girishkumar Sanghani is associated with 1 company as Director, including Viveda Wellness Retreat Private Limited (₹5.98 Cr).
Kumudini Girishkumar Sanghani has expertise in General Business.
Kumudini Girishkumar Sanghani has 5 years in corporate governance.
By reported revenue, the largest current company of Kumudini Girishkumar Sanghani is Viveda Wellness Retreat Private Limited, with revenue of ₹5.98 Cr (FY 2024).
Kumudini Girishkumar Sanghani currently holds positions at 1 company: Viveda Wellness Retreat Private Limited (₹5.98 Cr).